tiprankstipranks
Advertisement
Advertisement

ANVS Stock Latest News

Annovis Bio Completes Enrollment in Pivotal Alzheimer’s Trial
Company AnnouncementsAnnovis Bio Completes Enrollment in Pivotal Alzheimer’s Trial
20d ago
8K
ANVS
Annovis Bio initiated with a Buy at Roth Capital
PremiumThe Fly
Annovis Bio initiated with a Buy at Roth Capital
23d ago
ANVS
Annovis Bio announces full enrollment for buntanetap trial
PremiumThe Fly
Annovis Bio announces full enrollment for buntanetap trial
23d ago
ANVS
Annovis Bio promotes Cheng Fang to chief scientific officer
PremiumThe Fly
Annovis Bio promotes Cheng Fang to chief scientific officer
29d ago
ANVS
Annovis Bio Shareholders Approve Governance and Compensation Changes
PremiumCompany Announcements
Annovis Bio Shareholders Approve Governance and Compensation Changes
1M ago
8K
ANVS
Annovis Bio: Buy Rating Reiterated as Late-Stage Neurodegenerative Pipeline Advances; $8 Price Target Unchanged
PremiumRatingsAnnovis Bio: Buy Rating Reiterated as Late-Stage Neurodegenerative Pipeline Advances; $8 Price Target Unchanged
2M ago
ANVS
Annovis Bio regains NYSE listing compliance
Premium
The Fly
Annovis Bio regains NYSE listing compliance
2M ago
ANVS
Annovis Bio Announces Dilutive Equity Offering for Trials
Premium
Company Announcements
Annovis Bio Announces Dilutive Equity Offering for Trials
2M ago
8K
ANVS
Annovis Bio 7.9M share Spot Secondary priced at $1.90
PremiumThe Fly
Annovis Bio 7.9M share Spot Secondary priced at $1.90
2M ago
ANVS
Closing Bell Movers: Roblox up 4% on buyback, Keysight gains on earnings
PremiumThe Fly
Closing Bell Movers: Roblox up 4% on buyback, Keysight gains on earnings
2M ago
DRS
JHX
Annovis Bio announces common stock and warrants offering, no amount given
PremiumThe Fly
Annovis Bio announces common stock and warrants offering, no amount given
2M ago
ANVS
Annovis Bio Prices Registered Direct Offering to Fund Trials
PremiumCompany Announcements
Annovis Bio Prices Registered Direct Offering to Fund Trials
4M ago
8K
ANVS
Annovis Bio secures U.S. patent for buntanetap
PremiumThe FlyAnnovis Bio secures U.S. patent for buntanetap
4M ago
ANVS
Annovis Bio enters partnership with NeuroRPM
Premium
The Fly
Annovis Bio enters partnership with NeuroRPM
4M ago
ANVS
Annovis Bio sees cash runway to 3Q26
Premium
The Fly
Annovis Bio sees cash runway to 3Q26
5M ago
ANVS
Annovis Bio reports FY25 EPS ($1.40) vs. ($2.31) last year
PremiumThe Fly
Annovis Bio reports FY25 EPS ($1.40) vs. ($2.31) last year
5M ago
ANVS
Annovis Bio: Advancing Phase 3 Neurodegeneration Programs Create Attractive Risk‑Reward Supporting Buy Rating
PremiumRatings
Annovis Bio: Advancing Phase 3 Neurodegeneration Programs Create Attractive Risk‑Reward Supporting Buy Rating
5M ago
ANVS
Annovis Bio Advances Alzheimer’s Phase 3 Trial After Safety Nod
PremiumCompany Announcements
Annovis Bio Advances Alzheimer’s Phase 3 Trial After Safety Nod
6M ago
8K
ANVS
Annovis Bio secures DSMB approval to advance Phase 3 trial of buntanetap
PremiumThe Fly
Annovis Bio secures DSMB approval to advance Phase 3 trial of buntanetap
6M ago
ANVS
Annovis Bio Hosts Regulation FD Investor Information Webinar
PremiumCompany AnnouncementsAnnovis Bio Hosts Regulation FD Investor Information Webinar
6M ago
8K
ANVS
Annovis Bio reports open-label extension study for Parkinson’s disease patients
Premium
The Fly
Annovis Bio reports open-label extension study for Parkinson’s disease patients
7M ago
ANVS
Annovis Bio Advances Long-Term Buntanetap Safety Study in Parkinson’s Disease
Premium
Company Announcements
Annovis Bio Advances Long-Term Buntanetap Safety Study in Parkinson’s Disease
7M ago
ANVS

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >